Deferoxamine (DFO) is a medication used for iron (approved indication) and aluminum toxicity (off-label). It is in the chelator class of drugs. Deferoxamine chelates non-transferrin bound iron (free iron), iron in transit between transferrin and ferritin (labile chelating iron pool), hemosiderin, and ferritin. This activity will highlight the mechanism of action, adverse reactions, interactions, and other factors such as off-label use, dosing, indications, monitoring, and pharmacokinetics. The information is pertinent for members of interprofessional teams in the treatment of iron toxicity and aluminum toxicity.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/20309
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABA - 1.0 Point; Credit Type(s): Lifelong Learning (ABA)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Adolescent Medicine, Ambulatory/Outpatient, Chemical Pathology, Critical Care Medicine, Forensic Pathology, Gastroenterology, General Operative Anesthesia, General Pediatrics, General Surgery, Hematology, Hematology (Blood, BM), Hospital Medicine, Internal Medicine, Pediatric Critical Care Medicine, Pediatric Gastroenterology, Pediatric Hematology-Oncology, Rheumatology
Subscribe
Login
0 Comments
Oldest